ECM
TXG icon

ExodusPoint Capital Management’s 10x Genomics TXG Stock Holding History

ExodusPoint Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-251,730
Closed -$2.94M – 2083
2025
Q3 		$2.94M Buy
+251,730
New +$3.28M 0.03% 597
2025
Q1 		– Sell
-188,430
Closed -$2.71M – 2004
2024
Q4 		$2.71M Sell
188,430
-366,528
-66% -$5.78M 0.02% 607
2024
Q3 		$12.5M Buy
554,958
+265,747
+92% +$5.49M 0.08% 196
2024
Q2 		$5.63M Buy
289,211
+123,479
+75% +$3.23M 0.04% 370
2024
Q1 		$6.22M Buy
+165,732
New +$7.28M 0.05% 329
2023
Q3 		– Sell
-107,718
Closed -$6.01M – 2162
2023
Q2 		$6.01M Buy
+107,718
New +$5.83M 0.05% 384
2023
Q1 		– Sell
-39,250
Closed -$1.43M – 2140
2022
Q4 		$1.43M Buy
+39,250
New +$1.28M 0.02% 787
2022
Q2 		– Sell
-19,563
Closed -$1.49M – 2468
2022
Q1 		$1.49M Buy
19,563
+14,942
+323% +$1.31M 0.02% 922
2021
Q4 		$688K Buy
+4,621
New +$708K 0.01% 1252
2021
Q3 		– Sell
-5,466
Closed -$1.07M – 2645
2021
Q2 		$1.07M Buy
+5,466
New +$989K 0.01% 980
2021
Q1 		– Sell
-22,326
Closed -$3.16M – 2624
2020
Q4 		$3.16M Sell
22,326
-31,255
-58% -$4.54M 0.03% 382
2020
Q3 		$6.68M Buy
+53,581
New +$5.62M 0.13% 138

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ExodusPoint Capital Management's TXG Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 251,730 shares — an estimated $2.94M sold.

ExodusPoint Capital Management first reported a position in TXG in Q3 2020 and held it in 12 quarters. The position peaked at $12.5M in Q3 2024. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • ExodusPoint Capital Management reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 251,730 10x Genomics shares in Q4 2025, an estimated $2.94M.
  • ExodusPoint Capital Management first reported a position in 10x Genomics in Q3 2020 and held it in 12 quarters.
  • ExodusPoint Capital Management's 10x Genomics position peaked at $12.5M in Q3 2024.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.